Mifepristone or GFW alone. Methods Ninety-eight patients with
hysteromyoma consecutively received administration of Mifepristone
and(or)GFW for 3 month. Moreover, the volume of hysteromyoma and
serum concentrations of follicle stimulating hormone(FSH), luteinizing
hormone(LH), estrogen(E
2)and pregnendione(P)were detected pre-
and post-treatment. Results Menstrual blood volum(MBV),
bradymenorrhea, menalgia, discomfort in hypogastrium were generally
ameliorated after 3 month treatment compared with that of pre-treatment,
especially in patients received drug combination as for MBV.
Furthermore, administration of Mifepristone and/or GFW significantly
decreased the serum concentrations of FSH, LH, E
2 and P(P<0.05).
Follow-up visit showed no rebound in patients received GFW.
Conclusion Drug combination of Mifepristone and GFW shows the
optimal effects on hystermyoma in our study, and is worth of clinical
application.
【 Key words 】 Mifepristone;Guizhi fuling wan(GFW);
Hysteromyoma
子宫肌瘤是 30~50 岁育龄期女性常见的良性肿瘤,临床患病率
高达 20%以上[1],常导致患者继发性贫血、不孕甚至流产等,严
重影响患者生活质量。对于瘤体体积小,临床症状轻微患者可采取
保守治疗,但治疗方案不一,疗效差别较大。米非司酮用于子宫肌
瘤治疗已有报道,但最佳用药剂量及时间尚需进一步研究[2],
桂枝茯苓加减丸根据患者病情随症相加减治疗子宫肌瘤,较成分
固定的方剂更符合中医辨证施治原则。本文回顾性分析了 98 例子宫
肌瘤患者桂枝茯苓加减丸与米非司酮联合用药或单独用药在治疗
子宫肌瘤中的作用,现报告如下。
1 资料与方法
1.1
一般资料 回顾性分析了 2004 年 8 月至 2010 年 10 月于我院
就诊的 98
例子宫肌瘤患者,纳入研究标准为:① 临床检查提示子
宫肌瘤。② 伴有月经量增多、经期延长、贫血、下腹痛或压迫症状,